Compañía de Transporte de Energía Eléctrica en Alta Tensión Transener S.A. (BCBA:TRAN)

Theseus Pharmaceuticals Income Statement

Financials in millions ARS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	359,707	340,072	284,076	98,235	33,766	24,587
Revenue Growth (YoY)	22.45%	19.71%	189.18%	190.93%	37.33%	24.73%
Fuel & Purchased Power	39.26	35.42	32.45	-	2.29	0.65
Operations & Maintenance	16,579	17,407	36,588	7,281	1,781	725.42
Selling, General & Admin	4,009	4,026	4,573	9,301	440.6	212.2
Depreciation & Amortization	3,667	3,515	2,862	-	507.48	237.04
Other Operating Expenses	209,451	211,529	210,150	76,194	25,899	13,105
Total Operating Expenses	233,745	236,512	254,205	92,776	28,630	14,280
Operating Income	125,962	103,560	29,871	5,459	5,136	10,307
Interest Expense	1.37	-48.89	-1,821	-2,079	-1,723	-1,230
Interest Income	24,689	19,263	26,914	6,757	2,233	5.72
Net Interest Expense	24,691	19,215	25,094	4,678	509.41	-1,224
Currency Exchange Gain (Loss)	-2,118	-5,353	-3,176	178.42	-1,226	-1,486
Other Non-Operating Income (Expenses)	-31,977	-21,502	-32,279	-3,032	-1,014	376.63
EBT Excluding Unusual Items	116,557	95,919	19,510	7,283	3,405	7,973
Gain (Loss) on Sale of Investments	4,737	827.13	4,677	855.97	-23.47	999.66
Gain (Loss) on Sale of Assets	33.57	2,007	-1,068	13.52	-	-
Insurance Settlements	7,589	7,300	1,263	300.05	109.59	-
Pretax Income	128,918	106,054	24,381	8,453	3,491	8,973
Income Tax Expense	44,183	35,812	10,057	3,128	6,039	2,689
Earnings From Continuing Ops.	84,734	70,242	14,324	5,325	-2,548	6,284
Net Income	84,734	70,242	14,324	5,325	-2,548	6,284
Net Income to Common	84,734	70,242	14,324	5,325	-2,548	6,284
Net Income Growth	695.23%	390.37%	169.00%	-	-	15.84%
Shares Outstanding (Basic)	445	445	445	445	445	445
Shares Outstanding (Diluted)	445	445	445	445	445	445
Shares Change (YoY)	0.00%	-	-	-	-	-
EPS (Basic)	190.55	157.96	32.21	11.97	-5.73	14.13
EPS (Diluted)	190.55	157.96	32.21	11.97	-5.73	14.13
EPS Growth	695.21%	390.37%	169.00%	-	-	15.84%
Free Cash Flow	100,263	88,300	7,976	2,056	6,003	6,089
Free Cash Flow Per Share	225.48	198.57	17.94	4.62	13.50	13.69
Profit Margin	23.56%	20.66%	5.04%	5.42%	-7.55%	25.56%
Free Cash Flow Margin	27.87%	25.96%	2.81%	2.09%	17.78%	24.76%
EBITDA	164,019	141,479	66,112	22,252	10,619	12,947
EBITDA Margin	45.60%	41.60%	23.27%	22.65%	31.45%	52.66%
D&A For EBITDA	38,056	37,919	36,240	16,793	5,483	2,640
EBIT	125,962	103,560	29,871	5,459	5,136	10,307
EBIT Margin	35.02%	30.45%	10.51%	5.56%	15.21%	41.92%
Effective Tax Rate	34.27%	33.77%	41.25%	37.00%	172.99%	29.96%

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Utility template. Financial Sources.